Community Engagement in HIV Prevention Is a Disaster Management Plan
March 6, 2017
In an interview on behalf of IFARA at CROI 2017, Morenike Ukpong-Folayan spoke with Mark Hubbard and Stacey Hannah about addressing community concerns regarding medical research. The Good Participatory Practice (GPP) guidelines were initially developed for biomedical HIV prevention research. That first edition was then discussed with users around the globe, eventually resulting in version 2. This second edition broadened the scope to include policymakers, funders and others. GPP therefore now uses the term "stakeholder engagement."
Unlike Good Clinical Practice and Good Laboratory Practice guidelines, the GPP are not legally enforceable. Rather, they serve as a "comprehensive, structured and strategic ... scaffold" to be adapted to the specific research that is conducted, Mark Hubbard said. Groups in South Africa are trying to incorporate these guidelines into the ethics reviews of clinical trials. However, it is important to ensure that GPP does not simply become a list of checkboxes to be ticked off, but remains a guide to meaningful engagement.
The guidelines, along with training materials, are available on the AVACS website.
Watch the video to learn more:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.
Follow Barbara on Twitter: @reliabletran.
This article was provided by TheBodyPRO. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)